Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Technology Fee Schedule Inappropriate For OPPS, AdvaMed Tells MedPAC

This article was originally published in The Gray Sheet

Executive Summary

Technology items should not be removed from the hospital outpatient prospective payment system (OPPS) and be paid for under a separate fee schedule, according to AdvaMed

You may also be interested in...



OPPS 2003 Proposed Rule Contains Payment Cuts For 80% Of Devices – Scully

Ambulatory payment classification 0107 (insertion of cardioverter-defibrillator leads) faces a 51% payment rate reduction compared with its 2002 reimbursement level, according to the hospital outpatient prospective payment system (OPPS) proposed rule for 2003

OPPS 2003 Proposed Rule Contains Payment Cuts For 80% Of Devices – Scully

Ambulatory payment classification 0107 (insertion of cardioverter-defibrillator leads) faces a 51% payment rate reduction compared with its 2002 reimbursement level, according to the hospital outpatient prospective payment system (OPPS) proposed rule for 2003

MedPAC To Address Future Of “Pass-Through” Payments In March Report

The Medicare Payment Advisory Commission will consider long-term strategies for the reimbursement of medical technology in the hospital outpatient setting and make a recommendation in its March 2002 report to Congress

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel